GlobeNewswire·Jun 25, 2026, 8:00 AM ET

Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates

NNOX

Nano-X Imaging reported Q1 2026 revenue of $4.3 million, up from $2.8 million in the same period in 2025.
The company generated $3.1 million from teleradiology services, $167,000 from imaging system sales & deployment, and $1 million from AI & software solutions.
GAAP gross loss for the quarter was $2.6 million, while Non-GAAP gross loss narrowed to $0.2 million.
Net loss increased to $14.3 million from $13.2 million in the prior year period.
A Nanox.ARC system is currently operational at a RadNet facility, marking the first commercial integration into routine clinical workflow.
U.S. commercial partners began contributing sales leads as the company advanced execution of existing agreements.
The company suspended its 2026 annual revenue guidance due to longer-than-anticipated deployment timelines & revenue recognition delays.
Management does not intend to provide future annual revenue guidance, focusing instead on operational milestones like deployments & utilization.
Approximately 40 systems are currently in various stages of deployment, with 21 expected to be installed under the Nanox Imaging Network initiative.
The company entered distribution agreements for approximately 360 Capex systems in the U.S. over the next two to three years.
Restructuring evaluation for South Korea operations is ongoing, considering alternatives such as expansion, sale, or wind-down.
As of March 31, 2026, the company held $44.2 million in cash & equivalents, with management expressing substantial doubt about its ability to continue as a going concern for at least one year.
A class action lawsuit was filed on June 12, 2026, alleging securities law violations regarding the company's Korean manufacturing facility.
Shareholders' equity stood at $126.3 million with 69.6 million shares outstanding as of the reporting date.